Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 17 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 05, 2021 Filed Nov 5, 2021 22:24 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 14,302 | $35.00 | $500,570.00 |
DisclosureSEC source: 0001209191-21-063263 · doc4.xml · nonDerivative · entry 4 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,636 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 05, 2021 Filed Nov 5, 2021 22:24 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 14,302 | $1.12 | $16,018.24 |
DisclosureSEC source: 0001209191-21-063263 · doc4.xml · nonDerivative · entry 3 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:23 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $20.16 | $0.00 |
DisclosureSEC source: 0001209191-21-063260 · doc4.xml · derivative · entry 5 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 2,500 shares Expires 2030-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vested and is exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F3 · balance_after: In addition to the remaining options to purchase 93,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 137,500 shares of common stock, which options vest according to their terms. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:23 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $14.02 | $0.00 |
DisclosureSEC source: 0001209191-21-063260 · doc4.xml · derivative · entry 4 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,500 Underlying: Common Stock · 2,500 shares Expires 2029-12-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F3 · balance_after: In addition to the remaining options to purchase 93,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 137,500 shares of common stock, which options vest according to their terms. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:23 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
SaleCommon Stock | 5,000 | $35.00 | $175,000.00 |
DisclosureSEC source: 0001209191-21-063260 · doc4.xml · nonDerivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:23 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
Exercise / conversionCommon Stock | 2,500 | $20.16 | $50,400.00 |
DisclosureSEC source: 0001209191-21-063260 · doc4.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 18:23 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
Exercise / conversionCommon Stock | 2,500 | $14.02 | $35,050.00 |
DisclosureSEC source: 0001209191-21-063260 · doc4.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 22:24 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,059 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-21-063263 · doc4.xml · derivative · entry 5 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,302 Underlying: Common Stock · 6,059 shares Expires 2021-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option grant was issued on December 9, 2011, is fully vested and exercisable until its expiration date of December 8, 2021. F3 · balance_after: In addition to the remaining options to purchase 0 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 22:24 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 6,059 | $35.00 | $212,065.00 |
DisclosureSEC source: 0001209191-21-063263 · doc4.xml · nonDerivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,636 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 22:24 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 6,059 | $1.12 | $6,786.08 |
DisclosureSEC source: 0001209191-21-063263 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:53 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 36,646 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-21-062481 · doc4.xml · derivative · entry 4 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,645 Underlying: Common Stock · 36,646 shares Expires 2022-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option grant was issued on January 31, 2012 and became fully vested as of January 31, 2016, and is exercisable until its expiration date of January 31, 2022. F5 · balance_after: In addition to the remaining options to purchase 36,645 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,139,254 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:53 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 2,559 | $32.88 | $84,139.41 |
DisclosureSEC source: 0001209191-21-062481 · doc4.xml · nonDerivative · entry 3 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,636 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.85 to $32.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:53 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 34,087 | $32.27 | $1,099,967.04 |
DisclosureSEC source: 0001209191-21-062481 · doc4.xml · nonDerivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,195 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.84 to $32.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| November 01, 2021 Filed Nov 2, 2021 21:53 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 36,646 | $1.12 | $41,043.52 |
DisclosureSEC source: 0001209191-21-062481 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 23:54 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,993 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-21-061975 · doc4.xml · derivative · entry 3 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,291 Underlying: Common Stock · 15,993 shares Expires 2022-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option grant was issued on January 31, 2012 and became fully vested as of January 31, 2016, and is exercisable until its expiration date of January 31, 2022. F3 · balance_after: In addition to the remaining options to purchase 73,291 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,139,254 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 23:54 UTC |
Suria HamzaDirector · President, CEO
|
SaleCommon Stock | 15,993 | $30.00 | $479,790.00 |
DisclosureSEC source: 0001209191-21-061975 · doc4.xml · nonDerivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,636 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 23:54 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 15,993 | $1.12 | $17,912.16 |
DisclosureSEC source: 0001209191-21-061975 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 21:38 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-21-057077 · doc4.xml · derivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,361 Underlying: Common Stock · 10,000 shares Expires 2021-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F2 · balance_after: In addition to the remaining options to purchase 20,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,208,177 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 21:38 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 10,000 | $1.12 | $11,200.00 |
DisclosureSEC source: 0001209191-21-057077 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:50 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-21-032377 · doc4.xml · derivative · entry 2 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,361 Underlying: Common Stock · 10,000 shares Expires 2021-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested and immediately exercisable. F2 · balance_after: In addition to the remaining options to purchase 30,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,208,177 shares of common stock, which options vest according to their terms, and (ii) 57,636 shares of common stock held directly. Read SEC document |
| May 12, 2021 Filed May 13, 2021 20:50 UTC |
Suria HamzaDirector · President, CEO
|
Exercise / conversionCommon Stock | 10,000 | $1.12 | $11,200.00 |
DisclosureSEC source: 0001209191-21-032377 · doc4.xml · nonDerivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 4, 2021 16:51 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 165,000 | $23.25 | $3,835,755.00 |
DisclosureSEC source: 0001567619-21-008992 · doc1.xml · nonDerivative · entry 3 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 7,520,424 F4 · shares: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,374,066 shares of the Issuer's Common Stock. F4 · balance_after: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,374,066 shares of the Issuer's Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| May 03, 2021 Filed May 4, 2021 16:51 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 20,800 | $23.31 | $484,872.96 |
DisclosureSEC source: 0001567619-21-008992 · doc1.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 7,355,424 F3 · shares: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,209,066 shares of the Issuer's Common Stock. F3 · balance_after: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,209,066 shares of the Issuer's Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| April 30, 2021 Filed May 4, 2021 16:51 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 35,700 | $23.16 | $826,815.57 |
DisclosureSEC source: 0001567619-21-008992 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 7,334,624 F2 · shares: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,188,266 shares of the Issuer's Common Stock. F2 · balance_after: Qualified Fund purchased all of the securities in this transaction. After the transaction, Qualified Fund held 6,188,266 shares of the Issuer's Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| April 27, 2021 Filed Apr 27, 2021 18:23 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 33,800 | $23.82 | $805,088.96 |
DisclosureSEC source: 0001567619-21-008650 · doc1.xml · nonDerivative · entry 3 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 7,298,924 F2 · shares: Qualified Fund purchased all of the securities described in this transaction. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| April 26, 2021 Filed Apr 27, 2021 18:23 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 13,900 | $23.80 | $330,858.92 |
DisclosureSEC source: 0001567619-21-008650 · doc1.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 7,265,124 F2 · shares: Qualified Fund purchased all of the securities described in this transaction. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 18:23 UTC |
EcoR1 Capital, LLCDirector · 10% owner
NODELMAN OLEGDirector · 10% owner
|
PurchaseCommon Stock | 99,600 | $23.54 | $2,344,285.20 |
DisclosureSEC source: 0001567619-21-008650 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · Director · 10% owner NODELMAN OLEG · CIK 0001454385 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 7,251,224 F2 · shares: Qualified Fund purchased all of the securities described in this transaction. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1 and a director of the Issuer. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 22:53 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 531,000 | $18.70 | $9,928,425.60 |
DisclosureSEC source: 0001567619-21-006040 · doc1.xml · nonDerivative · entry 2 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 7,151,624 F3 · shares: Qualified Fund purchased 445,987 shares of the Common Stock purchased in this transaction. After this transaction, Qualified Fund held 6,005,266 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 22:53 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 2,777,800 | $18.97 | $52,694,310.44 |
DisclosureSEC source: 0001567619-21-006040 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 6,620,624 F2 · shares: Qualified Fund purchased 2,333,073 shares of the Common Stock purchased in this transaction. After this transaction, Qualified Fund held 5,559,279 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:58 UTC |
EcoR1 Capital, LLC10% owner
|
PurchaseCommon Stock | 29,500 | $25.48 | $751,657.05 |
DisclosureSEC source: 0001567619-21-004961 · doc1.xml · nonDerivative · entry 1 EcoR1 Capital, LLC · CIK 0001587114 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 3,842,824 F2 · shares: Qualified Fund purchased 13,862 shares of the Common Stock purchased in this transaction. After this transaction, Qualified Fund owned 3,226,206 shares of Common Stock. F1 · ownership.nature: The filing persons (the "Filers" are EcoR1 Capital, LLC ("EcoR1"), Oleg Nodelman and EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund"). EcoR1 is the investment adviser and general partner of private funds, including Qualified Fund (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 4 for itself, Mr. Nodelman and Qualified Fund. The Filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Read SEC document |
| February 12, 2021 Filed Feb 12, 2021 21:28 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $14.02 | $0.00 |
DisclosureSEC source: 0001209191-21-010517 · doc4.xml · derivative · entry 4 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,000 Underlying: Common Stock · 10,000 shares Expires 2029-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vested as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. F4 · balance_after: In addition to the remaining option to purchase 88,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 147,500 shares of common stock, which options vest according to their terms. Read SEC document |
| February 12, 2021 Filed Feb 12, 2021 21:28 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
SaleCommon Stock | 10,000 | $35.00 | $350,000.00 |
DisclosureSEC source: 0001209191-21-010517 · doc4.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transaction reported on this Form 4 were effected pursuant to a Rule 105b-1 trading plan adopted by the reporting person. Read SEC document |
| February 12, 2021 Filed Feb 12, 2021 21:28 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
Exercise / conversionCommon Stock | 10,000 | $14.02 | $140,200.00 |
DisclosureSEC source: 0001209191-21-010517 · doc4.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:24 UTC |
Ware J. AnthonyDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010512 · doc4.xml · derivative · entry 1 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:42 UTC |
Lizzul Paul F.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010533 · doc4.xml · derivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:36 UTC |
Schmid John P.Director
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010527 · doc4.xml · derivative · entry 1 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 21:28 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010517 · doc4.xml · derivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2031-02-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:26 UTC |
FENTON DENNIS MDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010513 · doc4.xml · derivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:44 UTC |
RENTON HOLLINGSDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010534 · doc4.xml · derivative · entry 1 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:27 UTC |
MULROY DENNISChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010514 · doc4.xml · derivative · entry 1 MULROY DENNIS · CIK 0001276840 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:36 UTC |
Topper James NDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010526 · doc4.xml · derivative · entry 1 Topper James N · CIK 0001341382 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:40 UTC |
Hamill LauraDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010530 · doc4.xml · derivative · entry 1 Hamill Laura · CIK 0001751804 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:40 UTC |
Marquet MagdaDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010531 · doc4.xml · derivative · entry 1 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| February 10, 2021 Filed Feb 13, 2021 02:29 UTC |
Suria HamzaDirector · President, CEO
|
GrantStock Option (right to buy) · Derivative | 119,700 | $0.00 Strike: $29.70 | $0.00 |
DisclosureSEC source: 0001209191-21-010518 · doc4.xml · derivative · entry 1 Suria Hamza · CIK 0001654495 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,700 Underlying: Common Stock · 119,700 shares Expires 2031-02-09 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| January 18, 2021 Filed Jan 19, 2021 21:36 UTC |
Marquet MagdaDirector
|
GrantStock Option (right to buy) · Derivative | 784 | $0.00 Strike: $26.11 | $0.00 |
DisclosureSEC source: 0001209191-21-004027 · doc4.xml · derivative · entry 2 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 784 Underlying: Common Stock · 784 shares Expires 2031-01-17 F2 · derivative.exercise_date: The stock option shall be fully vested as of February 12, 2021, subject to the Reporting Person's continued service on the vesting date. Read SEC document |
| January 18, 2021 Filed Jan 19, 2021 21:36 UTC |
Marquet MagdaDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $26.11 | $0.00 |
DisclosureSEC source: 0001209191-21-004027 · doc4.xml · derivative · entry 1 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2031-01-17 F1 · derivative.exercise_date: The stock option vests as to 1/36 of the total shares monthly beginning on February 18, 2021 until fully vested, subject to the Reporting Person's continued service on each vesting date. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:15 UTC |
Topper James NDirector
|
OtherCommon Stock | 26,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-059179 · doc4.xml · nonDerivative · entry 5 Topper James N · CIK 0001341382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,812 F8 · kind: Shares acquired by Dr. Topper through a distribution in-kind from Frazier Healthcare VII, L.P. F9 · balance_after: Dr. Topper also holds stock options to purchase up to an aggregate of 38,000 shares of the Issuer's Common Stock, which stock options vest according to their terms, in addition to the 80,812 shares of Common Stock that are held directly by Dr. Topper. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:15 UTC |
Topper James NDirector
|
OtherCommon Stock | 22,604 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-059179 · doc4.xml · nonDerivative · entry 4 Topper James N · CIK 0001341382 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,458 F7 · kind: Shares acquired by Dr. Topper through a distribution in-kind from Frazier Healthcare V, L.P. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:15 UTC |
Topper James NDirector
|
OtherCommon Stock | 98,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-059179 · doc4.xml · nonDerivative · entry 3 Topper James N · CIK 0001341382 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Frazier Healthcare VII-A, L.P. Disclosed balance after: 199,529 F5 · kind: Represents a pro rata distribution in-kind by Frazier Healthcare VII-A, L.P. to its limited partners for no consideration. F6 · ownership.nature: The reportable securities are held directly by Frazier Healthcare VII-A, L.P. FHM VII, L.P. is the general partner of Frazier Healthcare VII-A, L.P. FHM VII, L.L.C. is the general partner of FHM VII, L.P. James Topper is one of six managing members of FHM VII, L.L.C. Dr. Topper disclaims beneficial ownership of the securities held by Frazier Healthcare VII-A, L.P., except to the extent of his pecuniary interest therein, if any. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 22:15 UTC |
Topper James NDirector
|
OtherCommon Stock | 344,860 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-059179 · doc4.xml · nonDerivative · entry 2 Topper James N · CIK 0001341382 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Frazier Healthcare VII, L.P. Disclosed balance after: 700,171 F3 · kind: Represents a pro rata distribution in-kind by Frazier Healthcare VII, L.P. to its limited partners for no consideration. F4 · ownership.nature: The reportable securities are held directly by Frazier Healthcare VII, L.P. FHM VII, L.P. is the general partner of Frazier Healthcare VII, L.P. FHM VII, L.L.C. is the general partner of FHM VII, L.P. James Topper is one of six managing members of FHM VII, L.L.C. Dr. Topper disclaims beneficial ownership of the securities held by Frazier Healthcare VII, L.P., except to the extent of his pecuniary interest therein, if any. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.